(secondQuint)Cefepime vs.

 Ceftriaxone to Treat Nursing Home-Acquired Pneumonia.

 To compare the efficacy, safety, and pharmacoeconomics of cefepime versus ceftriaxone.

 Double-blind study of nursing home residents >60 years of age with pneumonia.

 Patients were randomized to cefepime or ceftriaxone 1 gm q24h to be administered intramuscularly.

 After three days, responding patients could be switched to oral antibiotics.

 Main Outcome Measures: clinical success, adverse events, and cost-effectiveness ratios.

.

 Cefepime vs.

 Ceftriaxone to Treat Nursing Home-Acquired Pneumonia@highlight

Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime is a safe, efficacious, and cost-effective alternative to once daily intramuscular ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do not require hospitalization.

